MedTrace Logo

Impact of Gabapentin on Slow Wave Sleep in Adult Critically Ill Patient

NCT04818450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-08-11

No results posted yet for this study

Summary

The investigators proposed that gabapentin will increase slow-wave sleep in adult critically ill patients. Increasing slow-wave sleep will improve the patients' outcomes (shortening ICU length of stay, improving ventilator free days, increasing delirium free days) in critically ill patients, a university hospital, Thailand.

Conditions

  • Sleep Deprivation
  • Critically Ill

Interventions

DRUG

Gabapentin

Gabapentin 100-300 mg is given to the intervention group

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Yuda Sutherasan, MD · Ramathibodi hospital, Mahidol university

  • Kanyarat Susantitapong, B.Sc.(Pharm) · Mahidol University

  • Pitchaya Dilokpattanamongkol, BCPS, BCCCP, BCP · Mahidol University

  • Chuthamanee Suthisisang, Ph.D. · Mahidol University

  • Viratch Tangsujaritvijit, Ph.D. · Piyavate Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2022-06-25
Completion
2022-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04818450 on ClinicalTrials.gov